National Geographic USA – June 2019

KEYTRUDA is a prescription medicine used to treat a kind

of lung cancer called NSCLC. KEYTRUDA may be used with

the chemotherapy medicines pemetrexed and a platinum as

ÞÕÀwÀÃÌÌÀi>ÌiÌÜiÞÕÀÕ}V>ViÀ>ÃëÀi>`

(advanced NSCLC) and is a type called “nonsquamous”

and your tumor does not have an abnormal “EGFR” or

ºƂ»}ii°



,ri«`iÀ>}ÀÜÌv>VÌÀÀiVi«ÌÀÆƂr>>«>ÃÌV

Þ«>>Ãi°

IMPORTANT SAFETY INFORMATION

KEYTRUDA is a medicine that may treat certain cancers by

ÜÀ}ÜÌÞÕÀÕiÃÞÃÌi°

9/,1ƂV>V>ÕÃi

ÞÕÀÕiÃÞÃÌiÌ>ÌÌ>VÀ>À}>Ã>`ÌÃÃÕiÃ>Þ

>Ài>vÞÕÀL`Þ>`V>>vviVÌÌiÜ>ÞÌiÞÜÀ°/iÃi

«ÀLiÃV>ÃiÌiÃLiViÃiÛiÀiÀviÌÀi>Ìi}

>`V>i>`Ì`i>Ì°/iÃi«ÀLiÃ>Þ>««i>ÞÌi

`ÕÀ}ÌÀi>ÌiÌÀiÛi>vÌiÀÞÕÀÌÀi>ÌiÌ>Ãi`i`°

Call or see your doctor right away if you develop any

symptoms of the following problems or these symptoms

get worse:

• Lung problems (pneumonitis).-Þ«ÌÃv«iÕÌÃ
  >ÞVÕ`iÃÀÌiÃÃvLÀi>Ì]ViÃÌ«>]ÀiÜÀÜÀÃi
  VÕ}°


• Intestinal problems (colitis) that can lead to tears or holes
  in your intestine.-}Ã>ÃÞ«ÌÃvVÌÃ>ÞVÕi
  `>ÀÀi>ÀÀiLÜiÛiiÌÃÌ>ÕÃÕ>ÆÃÌÃÌ>Ì

  
  

  ÀiL>V]Ì>ÀÀÞ]ÃÌVÞ]À>ÛiLÀÕVÕÃÆÀÃiÛiÀi ÃÌ>V>Ài>­>Li®«>ÀÌi`iÀiÃð

  
  

  
  


• Liver problems (hepatitis). -}Ã>ÃÞ«ÌÃvi«>ÌÌÃ >ÞVÕiÞiÜ}vÞÕÀÃÀÌiÜÌiÃvÞÕÀiÞiÃ]
  >ÕÃi>ÀÛÌ}]«>ÌiÀ}ÌÃ`ivÞÕÀÃÌ>V

>Ài>­>L`i®]`>ÀÕÀi]vii}iÃÃÕ}ÀÞÌ>ÕÃÕ>]

ÀLii`}ÀLÀÕÃ}Àii>ÃÞÌ>À>°

• Hormone gland problems (especially the thyroid,
  pituitary, adrenal glands, and pancreas). -}Ã> ÃÞ«ÌÃÌ>ÌÞÕÀÀi}>Ã>ÀiÌÜÀ}
  «À«iÀÞ>ÞVÕiÀ>«i>ÀÌLi>Ì]Üi}ÌÃÃÀÜi}Ì
  }>]VÀi>ÃiÃÜi>Ì}]vii}ÀiÕ}ÀÞÀÌÀÃÌÞ] ÕÀ>Ì}ÀivÌiÌ>ÕÃÕ>]>ÀÃÃ]vii}V]
  VÃÌ«>Ì]ÞÕÀÛVi}iÌÃii«iÀ]ÕÃVi>ViÃ]ââiÃÃ
  Àv>Ì}]Ài>>ViÃÌ>ÌÜÌ}>Ü>ÞÀÕÕÃÕ> i>>Vi°


• Kidney problems, including nephritis and kidney failure.
  -}ÃviÞ«ÀLiÃ>ÞVÕiV>}iÌi>ÕÌ
  ÀVÀvÞÕÀÕÀi°


• Skin problems.-}ÃvëÀLiÃ>ÞVÕ`iÀ>Ã]
  ÌV}]LÃÌiÀÃ]«ii}ÀÃÃÀiÃ]À«>vÕÃÀiÃÀ
  ÕViÀÃÞÕÀÕÌÀÞÕÀÃi]ÌÀ>Ì]À}iÌ>>Ài>°


• Problems in other organs.-}Ã>ÃÞ«ÌÃvÌiÃi «ÀLiÃ>ÞVÕiV>}iÃiÞiÃ}ÌÆÃiÛiÀiÀ
  «iÀÃÃÌiÌÕÃViÀÌ«>ÃÆÃiÛiÀiÕÃViÜi>iÃÃÆÜ
  ÀiLVií>i>®ÆÃÜiÞ«iÃ]À>ÃÀÌiiÀ
  Õ«ÃÃ]VÕ}]ÃÀÌiÃÃvLÀi>Ì]ÛÃV>}iÃ]À
  iÞi«>­Ã>ÀVÃîÆVvÕÃ]viÛiÀ]ÕÃViÜi>iÃÃ] L>>Vi«ÀLiÃ]>ÕÃi>]ÛÌ}]ÃÌvviV]iÀÞ «ÀLiÃ]ÀÃiâÕÀiíiVi«>ÌîÆ>ÃÀÌiÃÃvLÀi>Ì]
  ÀÀi}Õ>Ài>ÀÌLi>Ì]vii}ÌÀi]ÀViÃÌ«>­ÞV>ÀÌî°


• Infusion (IV) reactions that can sometimes be severe and
  life-threatening.-}Ã>ÃÞ«ÌÃvvÕÃÀi>VÌÃ >ÞVÕiVÃÀÃ>}]ÃÀÌiÃÃvLÀi>ÌÀ
  Üiiâ}]ÌV}ÀÀ>Ã]yÕÃ}]`ââiÃÃ]viÛiÀ]Àvii}
  i«>ÃÃ}ÕÌ°

KEYTRUDA immunotherapy + chemotherapy (pemetrexed and a

platinum) for advanced nonsquamous, non–small cell lung cancer that

does not have an abnormal EGFR or ALK gene.

Important Safety Information is continued on the next page.

“ TREATMENTS LIKE KEYTRUDA WITH

CHEMOTHERAPY REALLY BREAK THROUGH

BARRIERS WE HAD NOT LONG AGO.”

—DR. GOETZ KLOECKER

KEYTRUDA will not work for everyone. Results may vary.

WHEN TREATED WITH A COMBINATION OF KEYTRUDA AND CHEMOTHERAPY:

ƂVV>ÌÀ>V«>Ài«>ÌiÌÃÜÌ>Û>ViÃμÕ>ÕÃ]qÃ>ViÕ}V>ViÀ­ -  ® ÜÀiViÛi
9/,1 ƂVL>ÌÜÌViÌiÀ>«Þ­{£ä«>ÌiÌîÜÌÌÃiÜÀiViÛi ViÌiÀ>«Þ>i­ÓäÈ«>ÌiÌî°*>ÌiÌÃÌiÌÀ>`Ì>Ûi>>LÀ>
,ÀƂ}ii

>«ÀiÛÕÃ`ÀÕ}ÌÀi>ÌiÌ°

69% of patients taking KEYTRUDA with chemotherapy

were alive compared with 48% taking chemotherapy alone.

MORE PATIENTS LIVED LONGER

48% of patients taking KEYTRUDA with chemotherapy

saw their tumors shrink compared with 19% taking

chemotherapy alone.

MORE PATIENTS SAW THEIR TUMORS SHRINK

The median duration of response to treatment was 11.2 months for patients treated with a combination of
KEYTRUDA and chemotherapy compared with 7.8 months for those on chemotherapy alone.